专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20090318486A1 Tricyclic spiro derivatives as CRTH2 modulators 失效
标题翻译：三环螺衍生物作为CRTH2调节剂
公开(公告)号：US20090318486A1
公开(公告)日：2009-12-24
申请号：US11919471
申请日：2006-05-23
申请人： Matthias Schwarz , Eric Sebille , Christophe Cleva , Cedric Merlot , Dennis Church , Patrick Page , Jacqueline A. Macritchie , John Frederick Atherall , Stefano Crosignani , Doris Pupowicz
发明人： Matthias Schwarz , Eric Sebille , Christophe Cleva , Cedric Merlot , Dennis Church , Patrick Page , Jacqueline A. Macritchie , John Frederick Atherall , Stefano Crosignani , Doris Pupowicz
IPC分类号： A61K31/437 , C07D487/10 , A61K31/427 , C07D471/04 , A61P25/00
CPC分类号： C07D487/10
摘要： The present invention is related to the use of spiro derivatives of Formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of spiro derivatives for the modulation of CRTH2 activity.
摘要翻译：本发明涉及式（I）的螺衍生物用于治疗和/或预防具有炎性成分的过敏性疾病，炎性皮肤病和其它疾病的用途。具体地说，本发明涉及螺衍生物用于调节CRTH2活性的用途。

2. 发明授权

US07576212B2 Thieno[2,3-B] pyridines as potassium channel inhibitors 失效
标题翻译：噻吩并[2,3-B]吡啶作为钾通道抑制剂
公开(公告)号：US07576212B2
公开(公告)日：2009-08-18
申请号：US11297330
申请日：2005-12-09
申请人： John Ford , Nicholas John Palmer , John Frederick Atherall , David John Madge , Derek John
发明人： John Ford , Nicholas John Palmer , John Frederick Atherall , David John Madge , Derek John
IPC分类号： C07D513/02
CPC分类号： C07D495/04 , C07D333/36 , C07D333/38 , C07D409/12
摘要： The invention provides compounds of the formula: wherein R1 is aryl, heteroaryl, cycloalkyl or alkyl; R2 is H, alkyl, nitro, CO2R7, CONR5R6 or halo; R3 and R4 are H, NR5R6, NC(O)R7, halo, trifluromethyl, alkyl, CONR5R6, CO2R7, nitrile or alkoxy; R5 and R6 may be the same or different and may be H, alkyl, aryl, heteroaryl or cycloalkyl; or R5 and R6 may together form a saturated, unsaturated or partially saturated 4 to 7 member ring, wherein said ring may optionally comprise one or more further heteroatoms selected from N, O or S; R7 is H or alkyl; A is H, halo, or a group of formula X-L-Y; X is O, S or NR8; R8 is H or alkyl; L is (CH2)n, where n is 0, 1, 2, 3 or 4; and Y is aryl, a heterocyclic group, alkyl, alkenyl or cycloalkyl; the products of mono- and di-oxidation of sulphur and/or mono-oxidation of nitrogen moieties in compounds of formula I; or a pharmaceutically acceptable salt thereof. These compounds find use as inhibitors of potassium ion channels and thus are useful in the treatment of various conditions including arrhythmia and type-2 diabetes mellitus.
摘要翻译：本发明提供下式的化合物：其中R1是芳基，杂芳基，环烷基或烷基; R2是H，烷基，硝基，CO 2 R 7，CONR 5 R 6或卤素; R3和R4是H，NR5R6，NC（O）R7，卤素，三氟甲基，烷基，CONR5R6，CO2R7，腈或烷氧基; R5和R6可以相同或不同，可以是H，烷基，芳基，杂芳基或环烷基; 或R 5和R 6可以一起形成饱和的，不饱和的或部分饱和的4至7元环，其中所述环可任选地包含一个或多个选自N，O或S的其它杂原子; R7是H或烷基; A是H，卤素或式X-L-Y基团; X是O，S或NR8; R8是H或烷基; L是（CH 2）n，其中n是0,1,2,3或4; Y为芳基，杂环基，烷基，链烯基或环烷基; 式I化合物中硫的单和二氧化和/或氮部分的单氧化的产物; 或其药学上可接受的盐。这些化合物可用作钾离子通道的抑制剂，因此可用于治疗各种病症，包括心律失常和2型糖尿病。

3. 发明申请

US20100041695A1 Thieno[2,3-b]pyridines as Potassium Channel Inhibitors 有权
标题翻译：噻吩并[2,3-b]吡啶作为钾通道抑制剂
公开(公告)号：US20100041695A1
公开(公告)日：2010-02-18
申请号：US12543151
申请日：2009-08-18
申请人： John FORD , Nicholas John PALMER , John Frederick ATHERALL , David John MADGE , Derek JOHN
发明人： John FORD , Nicholas John PALMER , John Frederick ATHERALL , David John MADGE , Derek JOHN
IPC分类号： A61K31/4436 , A61P9/06 , A61P19/02 , A61P29/00 , A61P1/00 , A61P3/10
CPC分类号： C07D495/04 , C07D333/36 , C07D333/38 , C07D409/12
摘要： The invention provides compounds of the formula: wherein R1 is aryl, heteroaryl, cycloalkyl or alkyl; R2 is H, alkyl, nitro, CO2R7, CONR5R6 or halo; R3 and R4 are H, NR5R6, NC(O)R7, halo, trifluoromethyl, alkyl, CONR5R6, CO2R7, nitrile or alkoxy; R5 and R6 may be the same or different and may be H, alkyl, aryl, heteroaryl or cycloalkyl; or R5 and R6 may together form a saturated, unsaturated or partially saturated 4 to 7 member ring, wherein said ring may optionally comprise one or more further heteroatoms selected from N, O or S; R7 is H or alkyl; A is H, halo, or a group of formula X-L-Y; X is O, S or NR8; R8 is H or alkyl; L is (CH2)n, where n is 0, 1, 2, 3 or 4; and Y is aryl, a heterocyclic group, alkyl, alkenyl or cycloalkyl; the products of mono- and di-oxidation of sulphur and/or mono-oxidation of nitrogen moieties in compounds of formula I; or a pharmaceutically acceptable salt thereof. These compounds find use as inhibitors of potassium ion channels and thus are useful in the treatment of various conditions including arrhythmia and type-2 diabetes mellitus.
摘要翻译：本发明提供下式的化合物：其中R1是芳基，杂芳基，环烷基或烷基; R2是H，烷基，硝基，CO 2 R 7，CONR 5 R 6或卤素; R3和R4是H，NR5R6，NC（O）R7，卤素，三氟甲基，烷基，CONR5R6，CO2R7，腈或烷氧基; R5和R6可以相同或不同，可以是H，烷基，芳基，杂芳基或环烷基; 或R 5和R 6可以一起形成饱和的，不饱和的或部分饱和的4至7元环，其中所述环可任选地包含一个或多个选自N，O或S的其它杂原子; R7是H或烷基; A是H，卤素或式X-L-Y基团; X是O，S或NR8; R8是H或烷基; L是（CH 2）n，其中n是0,1,2,3或4; Y为芳基，杂环基，烷基，链烯基或环烷基; 式I化合物中硫的单和二氧化和/或氮部分的单氧化的产物; 或其药学上可接受的盐。这些化合物可用作钾离子通道的抑制剂，因此可用于治疗各种病症，包括心律失常和2型糖尿病。

4. 发明授权

US06893650B1 N2-phenylamidine derivatives 有权
标题翻译： N2-苯基脒衍生物
公开(公告)号：US06893650B1
公开(公告)日：2005-05-17
申请号：US09890775
申请日：2000-02-04
申请人： Mark David Charles , Wilfried Franke , David Eric Green , Thomas Lawley Hough , Dale Robert Mitchell , Donald James Simpson , John Frederick Atherall
发明人： Mark David Charles , Wilfried Franke , David Eric Green , Thomas Lawley Hough , Dale Robert Mitchell , Donald James Simpson , John Frederick Atherall
IPC分类号： C07D249/08 , A01N25/02 , A01N37/52 , A01N41/10 , A01N43/06 , A01N43/18 , A01N43/40 , A01N43/54 , A01N43/74 , A01N43/76 , A01N43/80 , A01N43/82 , A01N43/836 , A01N43/84 , A01N43/88 , A01N43/90 , A01N47/42 , A01P3/00 , C07C233/37 , C07C251/04 , C07C257/12 , C07C257/14 , C07C317/40 , C07C323/20 , C07C323/41 , C07D207/325 , C07D207/50 , C07D209/48 , C07D213/64 , C07D213/68 , C07D215/22 , C07D237/14 , C07D237/16 , C07D239/34 , C07D239/46 , C07D239/88 , C07D241/24 , C07D251/30 , C07D251/34 , C07D257/04 , C07D261/08 , C07D261/14 , C07D263/38 , C07D263/46 , C07D263/58 , C07D271/06 , C07D271/10 , C07D273/00 , C07D277/20 , C07D277/34 , C07D277/68 , C07D285/00 , C07D285/08 , C07D285/10 , C07D285/12 , C07D285/13 , C07D295/12 , C07D295/125 , C07D307/12 , C07D307/81 , C07D307/83 , C07D311/22 , C07D311/56 , C07D317/64 , C07D333/16 , C07D333/20 , C07D333/28 , C07D333/54 , C07D333/58 , C07D333/64 , C07D487/04 , C07D495/04 , C07F7/08 , A61K31/155 , C07D237/00 , C07D261/20 , C07D233/37
CPC分类号： C07D209/48 , A01N37/52 , A01N43/06 , A01N43/40 , A01N43/54 , A01N43/74 , A01N43/82 , A01N43/90 , A01N47/42 , C07C257/12 , C07C257/14 , C07D207/50 , C07D239/88 , C07D251/34 , C07D261/08 , C07D263/38 , C07D263/46 , C07D263/58 , C07D271/06 , C07D271/10 , C07D285/08 , C07D285/13 , C07D295/125 , C07D311/22 , C07D333/54 , C07D487/04 , C07D495/04 , C07F7/0812
摘要： The invention provides fungicidal compounds of formula (I) and salts thereof wherein: R1 is alkyl, alkenyl, alkynyl, carbocyclyl or heterocyclyl, each of which may be substituted, or hydrogen; R2 and R3, which may be the same or different, are any group defined for R1; cyano; acyl; —ORa or —SRa, where Ra is alkyl, alkenyl, alkynyl, carbocyclyl or heterocyclyl, each of which may be substituted; or R2 and R3, or R2 and R1, together with their interconnecting atoms may form a ring, which may be substituted; R4 is alkyl, alkenyl, alkynyl, carbocyclyl or heterocyclyl, each of which may be substituted; hydroxy; mercapto; azido; nitro; halogen; cyano; acyl; optionally substituted amino; cyanato; thiocyanato; —SF5; —ORa; —SRa or —Si(Ra)3; m is 0 to 3; when present R5, which may be the same or different to any other R5, is any group defined for R4; R6 is optionally substituted carbo- or heterocylclyl; and A is a defined linking group, or —A—R6 and R5 together with benzene ring M form an optionally substituted fused ring system.
摘要翻译：本发明提供式（I）的杀真菌化合物及其盐，其中：R 1是烷基，烯基，炔基，碳环基或杂环基，其各自可以被取代，或氢; R 2和R 3可以相同或不同，为R 1定义的任何基团; 氰基酰基; 其中R a是烷基，烯基，炔基，碳环基或杂环基，其各自可以被取代;或者其中R a，或R 2和R 3，或R 2和R 1以及它们的互连原子可以形成环，其可以被取代; R 4是烷基，烯基，炔基，碳环基或杂环基，其各自可以被取代; 羟基; 巯基叠氮硝基卤素; 氰基酰基; 任选取代的氨基; 青色硫氰酸 -SF 5; -OR ^{a ; -SR ^{a或-Si（R a a）3 3; m为0〜3; 当存在R 5可以与任何其它R 5相同或不同时，R 5为限定的任何基团。 R 6是任选取代的碳 - 或杂环基; 并且A是限定的连接基团，或者-A-R 6和R 5和苯环M一起形成任选取代的稠环体系。}}

5. 发明授权

US08389516B2 Antibacterial compositions 有权
标题翻译：抗菌组合物
公开(公告)号：US08389516B2
公开(公告)日：2013-03-05
申请号：US13154592
申请日：2011-06-07
申请人： David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
发明人： David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
IPC分类号： A61K31/5377 , A61K31/501 , A61K31/497 , A61K31/496 , A61K31/506 , A61K31/4436 , A61K31/428 , A61K31/429 , C07D239/42
CPC分类号： C07D417/04 , C07D417/14 , Y02P20/582
摘要： Compounds of formula (I) have antibacterial activity: wherein: m is 0 or 1; Q is hydrogen or cyclopropyl; Alk is an optionally substituted, divalent C1-C6 alkylene, alkenylene or alkynylene radical which may contain an ether (—O—), thioether (—S—) or amino (—NR)— link, wherein R is hydrogen, —CN or C1-C3 alkyl; X is —C(═O)NR6—, —S(O)NR6—, —C(═O)O— or —S(═O)O— wherein R6 is hydrogen, optionally substituted C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, -Cyc, or —(C1-C3 alkyl)-Cyc wherein Cyc is optionally substituted monocyclic carbocyclic or heterocyclic having 3-7 ring atoms; Z is N or CH, or CF; R2 and R3 are as defined in the description.
摘要翻译：式（I）化合物具有抗菌活性：其中：m为0或1; Q是氢或环丙基; Alk是可以含有醚（-O-），硫醚（-S-）或氨基（-NR） - 连接的任意取代的二价C1-C6亚烷基，亚烯基或亚炔基，其中R是氢，-CN或 C1-C3烷基; X是-C（= O）NR 6 - ， - S（O）NR 6 - ， - C（= O）O-或-S（= O）O-，其中R 6是氢，任选取代的C 1 -C 6烷基， C6链烯基，C2-C6炔基，-Cyc或 - （C1-C3烷基）-Cyc，其中Cyc是具有3-7个环原子的任选取代的单环碳环或杂环; Z是N或CH，或CF; R2和R3如说明书中所定义。

6. 发明授权

US07977340B2 Antibacterial compositions 有权
标题翻译：抗菌组合物
公开(公告)号：US07977340B2
公开(公告)日：2011-07-12
申请号：US12304303
申请日：2007-06-21
申请人： David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
发明人： David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
IPC分类号： A61K31/4412 , A61K31/4436 , A61K31/497 , A61K31/506 , C07D403/14 , C07D417/14
CPC分类号： C07D417/04 , C07D417/14 , Y02P20/582
摘要： Compounds of formula (I) have antibacterial activity: wherein: m is 0 or 1; Q is hydrogen or cyclopropyl; AIk is an optionally substituted, divalent C1-C6 alkylene, alkenylene or alkynylene radical which may contain an ether (—O—), thioether (—S—) or amino (—NR)— link, wherein R is hydrogen, —CN or C1-C3 alkyl; X is —C(═O)NR6—, —S(O)NR6—, —C(═O)O— or —S(═O)O— wherein R6 is hydrogen, optionally substituted C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, -Cyc, or —(C1-C3 alkyl)-Cyc wherein Cyc is optionally substituted monocyclic carbocyclic or heterocyclic having 3-7 ring atoms; Z is N or CH, or CF; R2 and R3 are as defined in the description.
摘要翻译：式（I）化合物具有抗菌活性：其中：m为0或1; Q是氢或环丙基; Alk是可以含有醚（-O-），硫醚（-S-）或氨基（-NR） - 连接的任意取代的二价C 1 -C 6亚烷基，亚烯基或亚炔基，其中R是氢，-CN或 C1-C3烷基; X是-C（= O）NR 6 - ， - S（O）NR 6 - ， - C（= O）O-或-S（= O）O-，其中R 6是氢，任选取代的C 1 -C 6烷基， C6链烯基，C2-C6炔基，-Cyc或 - （C1-C3烷基）-Cyc，其中Cyc是具有3-7个环原子的任选取代的单环碳环或杂环; Z是N或CH，或CF; R2和R3如说明书中所定义。

7. 发明申请

US20120004221A1 Antibacterial Compositions 有权
标题翻译：抗菌组合物
公开(公告)号：US20120004221A1
公开(公告)日：2012-01-05
申请号：US13154485
申请日：2011-06-07
申请人： David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
发明人： David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
IPC分类号： A61K31/437 , A01N43/90 , A61K31/497 , A01P1/00 , A61K31/5377 , A61K31/506 , A61K31/5383 , A61P31/04 , C07D513/04 , A61K31/496
CPC分类号： A61K31/437 , A01N47/36 , A61K31/4375 , A61K31/4439 , A61K31/444 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/5377 , A61K31/5383
摘要： Compounds of formula (I) have antibacterial activity: wherein: m is 0 or 1; Q is hydrogen or cyclopropyl; Alk is an optionally substituted, divalent C1-C6 alkylene, alkenylene or alkynylene radical which may contain an ether (—O—), thioether (—S—) or amino (—NR)— link, wherein R is hydrogen, —CN or C1-C3 alkyl; X is —C(═O)NR6—, —S(O)NR6—, —C(═O)O— or —S(═O)O— wherein R6 is hydrogen, optionally substituted C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, -Cyc, or —(C1-C3 alkyl)-Cyc wherein Cyc is optionally substituted monocyclic carbocyclic or heterocyclic having 3-7 ring atoms; Z is N; R2 and R3 are as defined in the description.
摘要翻译：式（I）化合物具有抗菌活性：其中：m为0或1; Q是氢或环丙基; Alk是可以含有醚（-O-），硫醚（-S-）或氨基（-NR） - 连接的任意取代的二价C1-C6亚烷基，亚烯基或亚炔基，其中R是氢，-CN或 C1-C3烷基; X是-C（= O）NR 6 - ， - S（O）NR 6 - ， - C（= O）O-或-S（= O）O-，其中R 6是氢，任选取代的C 1 -C 6烷基， C6链烯基，C2-C6炔基，-Cyc或 - （C1-C3烷基）-Cyc，其中Cyc是具有3-7个环原子的任选取代的单环碳环或杂环; Z是N; R2和R3如说明书中所定义。

8. 发明授权

US07456187B2 Furanopyrimidine compounds as potassium ion channel inhibitors 失效
标题翻译：呋喃并嘧啶化合物作为钾离子通道抑制剂
公开(公告)号：US07456187B2
公开(公告)日：2008-11-25
申请号：US11148991
申请日：2005-06-10
申请人： John Ford , Nicholas John Palmer , John Frederick Atherall , David John Madge
发明人： John Ford , Nicholas John Palmer , John Frederick Atherall , David John Madge
IPC分类号： C07D491/048 , A61K31/519 , A61P9/06
CPC分类号： C07D491/04
摘要： A compound of formula (I) wherein R1 is aryl, heteroaryl, cycloalkyl or alkyl; R2 is H, alkyl, nitro, —CO2R7, CONR4R5 or halo; R3 is H, NR4R5, NC(O)R8, halo, trifluoromethyl, alkyl, nitrile or alkoxy; R4 and R5 may be the same or different, and may be H, alkyl, aryl, heteroaryl or cycloalkyl; or R4 and R5 may together form a saturated, unsaturated or partially saturated 4 to 7 member ring, wherein said ring may optionally comprise one or more further heteroatoms selected from N, O or S; X is O, S or NR6; R6 is H or alkyl; R7 is hydrogen, methyl or ethyl; R8 is methyl or ethyl; L is (CH2)n, where n is 1, 2 or 3; and Y is aryl, a heterocyclic group, alkyl, alkenyl or cycloalkyl; together with pharmaceutically acceptable salts thereof. The use of these compounds as potassium channel inhibitors is also described.
摘要翻译：式（I）化合物，其中R 1是芳基，杂芳基，环烷基或烷基; R 2是H，烷基，硝基，-CO 2 R 7，CONR 4 R 5 /或卤素; R 3是H，NR 4 R 5，NC（O）R 8，卤素，三氟甲基，烷基，腈或烷氧基; R 4和R 5可以相同或不同，并且可以是H，烷基，芳基，杂芳基或环烷基; 或R 4和R 5可以一起形成饱和的，不饱和的或部分饱和的4至7元环，其中所述环可以任选地包含一个或多个其它选自N ，O或S; X是O，S或NR 6; R 6是H或烷基; R 7是氢，甲基或乙基; R 8是甲基或乙基; L是（CH 2 CH 2）n N，其中n是1,2或3; Y为芳基，杂环基，烷基，链烯基或环烷基; 以及其药学上可接受的盐。还描述了这些化合物作为钾通道抑制剂的用途。

9. 发明授权

US06541630B1 Fungicides 失效
标题翻译：杀菌剂
公开(公告)号：US06541630B1
公开(公告)日：2003-04-01
申请号：US10172891
申请日：2002-06-13
申请人： John Frederick Atherall , Thomas Lawley Hough , Stephen David Lindell , Mary Josephine O'Mahony , John Henry Parsons , Elizabeth Anne Saville-Stones
发明人： John Frederick Atherall , Thomas Lawley Hough , Stephen David Lindell , Mary Josephine O'Mahony , John Henry Parsons , Elizabeth Anne Saville-Stones
IPC分类号： C07D49504
CPC分类号： C07D495/04 , A01N43/90
摘要： The invention provides the use in combating fungi of compounds of general formula I wherein R1 is hydrogen, hydroxy, acyl, acyloxy, optionally substituted amino, Ra, Ra3Si, RaS or RaO, where Ra is optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkenyl, optionally substituted aryl or optionally substituted heterocyclyl; Z is oxygen or sulfur; M is a thiophene ring; and R3 and R4, which may be the same or different, have the same meaning as Ra or can be optionally substituted amino, hydrogen, halogen, cyano, nitro or a group ORc or S(O)mRc, where Rc has the same meaning as Ra or is hydrogen or acyl and m is 0, 1 or 2; or R3 and R4 together with the atoms to which they are attached form an optionally substituted carbocyclic or heterocyclic ring; together with tautomers of compounds where R1 is hydrogen.
摘要翻译：本发明提供了用于对抗通式I化合物的用途，其中R 1是氢，羟基，酰基，酰氧基，任选取代的氨基，R a，R 3 Si，RaS或RaO，其中R a是任选取代的烷基，任选取代的链烯基，炔基，任选取代的环烷基，任选取代的环烯基，任选取代的芳基或任选取代的杂环基; Z是氧或硫; M是噻吩环; 和R 3和R 4可以相同或不同，具有与R a相同的含义或可以是任选取代的氨基，氢，卤素，氰基，硝基或基团OR c或S（O）m R c，其中R c具有相同的含义为Ra或为氢或酰基，m为0,1或2; 或R 3和R 4与它们所连接的原子一起形成任选取代的碳环或杂环; 以及R1为氢的化合物的互变异构体。

10. 发明授权

US08481544B2 Antibacterial compositions 有权
标题翻译：抗菌组合物
公开(公告)号：US08481544B2
公开(公告)日：2013-07-09
申请号：US13154485
申请日：2011-06-07
申请人： David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
发明人： David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
IPC分类号： A61K31/497 , A61K31/4365 , C07D241/12 , C07D513/04
CPC分类号： A61K31/437 , A01N47/36 , A61K31/4375 , A61K31/4439 , A61K31/444 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/5377 , A61K31/5383
摘要： Compounds of formula (I) have antibacterial activity: wherein: m is 0 or 1; Q is hydrogen or cyclopropyl; Alk is an optionally substituted, divalent C1-C6 alkylene, alkenylene or alkynylene radical which may contain an ether (—O—), thioether (—S—) or amino (—NR)— link, wherein R is hydrogen, —CN or C1-C3 alkyl; X is —C(═O)NR6—, —S(O)NR6—, —C(═O)O— or —S(═O)O— wherein R6 is hydrogen, optionally substituted C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, -Cyc, or —(C1-C3 alkyl)-Cyc wherein Cyc is optionally substituted monocyclic carbocyclic or heterocyclic having 3-7 ring atoms; Z is N; R2 and R3 are as defined in the description.
摘要翻译：式（I）化合物具有抗菌活性：其中：m为0或1; Q是氢或环丙基; Alk是可以含有醚（-O-），硫醚（-S-）或氨基（-NR） - 连接的任意取代的二价C1-C6亚烷基，亚烯基或亚炔基，其中R是氢，-CN或 C1-C3烷基; X是-C（= O）NR 6 - ， - S（O）NR 6 - ， - C（= O）O-或-S（= O）O-，其中R 6是氢，任选取代的C 1 -C 6烷基， C6链烯基，C2-C6炔基，-Cyc或 - （C1-C3烷基）-Cyc，其中Cyc是具有3-7个环原子的任选取代的单环碳环或杂环; Z是N; R2和R3如说明书中所定义。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式